PMID: 16617383Apr 18, 2006Paper

First observations of the dose-dense weekly docetaxel therapy in relapsed ovarian cancer

Magyar onkologia
Ottó Lehoczky, Tamás Pulay

Abstract

Weekly docetaxel therapy is a new therapeutical form of relapsed ovarian cancer. Phase I and II trials of this administration form are rare in the literature of this tumor type. The authors report on a retrospective study of this treatment. Ten patients with recurrent epithelial ovarian carcinoma were treated by dose-dense weekly docetaxel in 57 courses. The patients received a median of 6 courses of docetaxel on day 1, 8 and 15 together with a one-week pause, in 4-week courses. The average age of the patients was 61+/-9 years. Eight patients received a docetaxel monotherapy at a dose of 40 mg/m2, in weekly administration, and two patients weekly docetaxel combination therapy with carboplatin of AUC 3, on the same days as above. The premedication used before docetaxel was the same as the one given in the 3-week protocols: the patients received treatments of 100 mg methyl-prednisolone 12 hours and half an hour before docetaxel infusion. No G4 hematological toxicities were observed. G3 and G2 leucopenia was found in 6/57=11% and 4/57=8% of treatments. No granulocyte colony stimulating factor was given. Progression-free interval (PFI) was calculated by GraphPad Prism (version 2.0) program. Complete response was found in two patien...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.